Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Monkey Antibodies Help Fight Chikungunya Virus

September 24, 2014 10:48 am | News | Comments

New research provides details of how the immune system responds to the chikungunya virus, findings that could support the development of vaccines and therapies. Read more...                      


NIH Funds Next Phase of Tissue Chip for Drug Screening Program

September 24, 2014 10:40 am | News | Comments

The National Institutes of Health will award funds to support the next phase of its Tissue Chip for Drug Screening program to improve ways of predicting drug safety and effectiveness. Read more...                            


WHO: Ebola Vaccine Could be Ready by Year-End

September 24, 2014 10:15 am | News | Comments

The World Health Organization (WHO) says a vaccine might be available in large enough quantities by the end of the year to help control West Africa's Ebola outbreak. Read more...                        


Baxter, Merrimack Collaborate on Pancreatic Cancer Drug

September 24, 2014 10:01 am | News | Comments

Shares of Merrimack Pharmaceuticals Inc. jumped Wednesday after the drugmaker said it could receive more than $900 million through a collaboration with Baxter International Inc. over its potential pancreatic cancer treatment. Read more...


Why We Need Antibiotics

September 23, 2014 3:42 pm | Videos | Comments

Antibiotics revolutionized health care in the early 20th century, helping kill bacteria that once killed thousands of people. Read more...                                   


Muscle-on-a-chip Mimics Asthma, May Help Test Drugs

September 23, 2014 3:38 pm | News | Comments

Hope for healthier airways may be on the horizon thanks to a human airway muscle-on-a-chip that could be used to test new drugs because it accurately mimics the way smooth muscle contracts in the human airway, under normal circumstances and when exposed to asthma triggers. Read more...


NIH Awards $35M for Centers for Collaborative Research in Fragile X

September 23, 2014 3:29 pm | News | Comments

NIH is awarding $35 million over the next five years to support the Centers for Collaborative Research in Fragile X program. Investigators at these centers will seek to better understand Fragile X-associated disorders and work toward developing effective treatments. Read more...


FDA Warns Doctors to Beware Fake Drug Distributors

September 23, 2014 2:44 pm | by Matthew Perrone, AP Health Writer | News | Comments

U.S. health regulators are trying to help doctors spot counterfeit and unapproved drugs by raising awareness of illegal operations that peddle bogus drugs to health professionals. Read more...                 


Investigational Drug Could be Treatment for AML, Multiple Myeloma

September 23, 2014 1:57 pm | News | Comments

The investigational drug CX-5461 prolonged survival in mouse models of highly aggressive AML and multiple myeloma, according to data presented at the AACR special conference Hematologic Malignancies: Translating Discoveries to Novel Therapies. Read more...


Clampdown on Tax Maneuver Leaves its Mark on Pharma

September 23, 2014 1:46 pm | News | Comments

A handful of big companies pursuing overseas mergers to lower their tax bills - including pharmaceutical company AbbVie - came under pressure Tuesday after the U.S. unveiled rules to discourage them. Read more...           


TKIs May Improve Treatment for Ph-Like ALL

September 23, 2014 11:28 am | News | Comments

Tyrosine kinase inhibitors (TKIs) may improve treatment outcome for children and young adults with Ph-like acute lymphoblastic leukemia (Ph-like ALL), a disease with dismal prognosis, according to new data. Read more...         


New Approach Aims to Silence Cancer 'Survival Genes'

September 23, 2014 11:20 am | News | Comments

Scientists are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death. Read more...                             


FDA Fast Tracks MedImmune’s Pneumonia Drug

September 23, 2014 11:07 am | News | Comments

AstraZeneca announced that its global biologics research and development arm, MedImmune, has received fast track designation from the FDA for its investigational monoclonal antibody MEDI3902 for the prevention of nosocomial pneumonia. Read more...


New Awards Apply Sex, Gender Lens to NIH-Funded Research

September 23, 2014 10:57 am | News | Comments

The NIH has invested $10.1 million in supplemental funding to bolster the research of 82 grantees to explore the effects of sex in preclinical and clinical studies. Read more...                     


Ebola Drug Trials to be Fast-Tracked in West Africa

September 23, 2014 10:48 am | News | Comments

Potential new treatments for Ebola are to be tested in West Africa for the first time as part of an international initiative to fast-track trials of the most promising drugs against the disease that has already led to over 2,600 deaths. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.